The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The pharmacokinetic profile of raltegravir-containing antiretroviral therapy in HIV-infected individuals over 60 years of age

Published:2015-01-14 Issue:1 Volume:16 Page:39-42
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Vera Jaime H.,Jackson Akil,Dickinson Laura,Else Laura,Barber Tristan,Mora-Peris Borja,Back David,Boffito Marta,Winston Alan

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

http://www.tandfonline.com/doi/pdf/10.1179/1528433614Z.0000000006

Reference22 articles.

1. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

2. HIV transmission and high rates of late diagnoses among adults aged 50 years and over

3. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity

4. HIV Infection and Older Americans: The Public Health Perspective

5. Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Evaluation of Ontogeny Functions of the Major UDP‐Glucuronosyltransferase Enzymes to Underwrite Physiologically Based Pharmacokinetic Modeling in Pediatric Populations;The Journal of Clinical Pharmacology;2024-06-19

2. Inhibition of HIV-1 release by ADAM metalloproteinase inhibitors;Frontiers in Microbiology;2024-03-20

3. Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV: A Systematic Review;Clinical Pharmacokinetics;2023-08-10

4. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

5. Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study;The Pharmacogenomics Journal;2022-10-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3